Adjunctive Passive Immunotherapy in Human Immunodeficiency Virus Type 1-Infected Individuals Treated with Antiviral Therapy during Acute and Early Infection

Three neutralizing monoclonal antibodies (MAbs), 2G12, 2F5, and 4E10, with activity in vitro and in vivo were administered in an open-label, nonrandomized, proof-of-concept study to attempt to prevent viral rebound after interruption of antiretroviral therapy (ART). Ten human immunodeficiency virus...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mehandru, Saurabh, Vcelar, Brigitta, Wrin, Terri, Stiegler, Gabriela, Joos, Beda, Mohri, Hiroshi, Boden, Daniel, Galovich, Justin, Tenner-Racz, Klara, Racz, Paul, Carrington, Mary, Petropoulos, Christos, Katinger, Hermann, Markowitz, Martin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2007
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2045579/
https://ncbi.nlm.nih.gov/pubmed/17686878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01340-07
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak